Kezar Life Sciences Inc — Balance Sheet (NASDAQ:KZR) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 151.84 M217.93 M299.57 M221.24 M144.68 M76.65 M Total liabilities 10.86 M21.06 M29.7 M33.66 M27.77 M6.57 M Total equity 140.98 M196.88 M269.87 M187.57 M116.92 M70.07 M Total liabilities & shareholders' equities 151.84 M217.93 M299.57 M221.24 M144.68 M76.65 M Total debt —9.62 M9.83 M10.07 M10.33 M0 Net debt —-198.73 M-266.73 M-191.3 M-121.92 M-71.88 M

News

Enodia acquires Kezar’s Sec61 program assets for $127M potential

Kezar Life Sciences (KZR) Upgraded to Buy: Here's What You Should Know

Kezar Life Sciences announces workforce reduction as part of restructuring

Kezar’s AIH drug shows promise in steroid reduction, trial data reveals

Kezar Life Sciences repays $6.3 million loan and ends agreement with Oxford Finance

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.52%

Kezar Launches Review After FDA Blocks Liver Drug Plans - Kezar Life Sciences (NASDAQ:KZR)

This Booz Allen Hamilton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Booz Allen Hamilton (NYSE:BAH), AST SpaceMobile (NASDAQ:ASTS)

William Blair downgrades Kezar Life Sciences stock rating on FDA setback

Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket - American Battery Tech (NASDAQ:ABAT), Achieve Life Sciences (NASDAQ:ACHV)

Jefferies downgrades Kezer Life Sciences stock on FDA setback

Kezar Life Sciences stock climbs as company seeks strategic alternatives